Cardiovascular Pharmacotherapy
Showing 24 of 1169 results
ESC Journals
Stent thrombosis associated with non-response to clopidogrel despite co-administration of aspirin and ibrutinib
21 May 2026
ESC Journals
Feasibility of hypnosis for analgosedation during atrial fibrillation ablation, including pulsed field and radiofrequency techniques: a pilot study
14 May 2026
ESC Journals
Disturbed flow induced targeting of nanomedicine to endothelial cells for effective atherosclerosis therapy
13 May 2026
Congress Session
Heart failure with preserved ejection fraction subtypes: pathophysiology and treatments
11 May 2026
Congress Session
Congress Session
Congress Session
Congress Session
ESC Journals
Differential effects of semaglutide and colchicine on atrial remodeling in rats with reduced ejection fraction after myocardial infarction
21 April 2026
ESC Journals
Development and validation of clinical prediction models for personalized renal function monitoring in people with heart failure in primary care: the RENAL-HF study protocol
31 March 2026
ESC Journals
Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology
31 March 2026
ESC Journals
Troponin T/I discordance in immune checkpoint inhibitor myositis in a patient with ischaemic cardiac disease: a case report
18 March 2026
ESC Journals
Efficacy of ranolazine in reducing complex premature ventricular contractions in a patient with mitral valve prolapse: a case report
18 March 2026
ESC Journals
VEGF-C-mediated cardiac lymphangiogenesis promotes inflammation resolution in autoimmune acute myocarditis in mice
17 March 2026
ESC Journals
Unravelling mitochondrial succinate transport during I/R and devising a novel transport inhibitor show promise for targeting I/R injury, but will efficacy remain under more human-like conditions present during I/R?
17 March 2026
ESC Journals
ESC Journals
Further mystification of <em>SCN5A</em> phenotypes: sodium channel blockade in individuals with loss-of-function sodium channel mutations dangerous or helpful?
11 March 2026
ESC Journals
Inflammation-associated rapidly progressive coronary artery disease: a case report
10 March 2026
ESC Journals
ESC Journals
Snake in the heart: a rare inferior vena cava to pulmonary artery thrombus in pregnancy
24 February 2026
ESC Journals
From stenosis to atheroma: repositioning lipoprotein(a) in coronary artery disease risk assessment
24 February 2026
Congress Session
Tailoring antithrombotic therapy after PCI: balancing ischaemic and bleeding risks
19 February 2026
ESC Journals
SEMA7A-mediated regulation of smooth muscle cell plasticity in AAA: a potential intersection with metabolic reprogramming in the aortic wall
16 February 2026
ESC Journals
Resolution of severe dilated cardiomyopathy with significant arrhythmia burden using hydroquinidine, in addition to guideline-directed medical therapy, in a patient with a pathogenic <em>SCN5A</em> variant: a case report
6 February 2026
